Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POETIC-A: Abemaciclib in Early Breast Cancer
NCT04584853Phase 3Active, not recruiting
- Sponsor
- The Institute of Cancer Research
- Start
- Dec 2020
- Primary completion
- Oct 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of abemaciclib in breast cancer, sponsored by The Institute of Cancer Research. Started Dec 2020; status: active, not recruiting.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04584853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04584853.